Corporate Profile  

Target Market 
 

Business Strategy
Our Story

Mission Statement

Officers & Key Personnel

Scientific Advisory Board

   
Mickael A. Flaa  
  Mickael Flaa

Vice President, Chief Financial Officer

Mr. Flaa is a CPA and a retired partner from KPMG. He joined CVBT in June 2003. Prior to these positions, he served as Interim Chief Financial Officer for publicly-held Breakaway Solutions, Inc., and as Chief Financial Officer and member of the Board of Directors for Sunbelt Integrated Trade Services, Inc.

Mr. Flaa is VP & CFO of Phage Biotechnology Corporation, a related party. He also remains involved in the management and/or board of directors of several additional ventures: Onnam Gaming, and Gestalt, LLC. Flaa spent 22 years in various management positions with KPMG Peat Marwick LLP, where he was elected to partnership in 1990. He worked with clients in fields including health care, technology, utilities, transportation and energy. Flaa received his undergraduate degree from Central Washington University.

 

 

< Back to Officers & Key Personnel

 

 

 

 

 

Use of this site constitutes agreement to our Terms and Conditions
and Privacy Policy. Site Design and Contents © 2008 CardioVascular BioTherapeutics, Inc. All Rights Reserved.

Some content on this site requires the free Adobe Reader.

 

11/13/2008
CVBT Closes Clinical Development Agreement for Coronary Heart Disease Drug Candidate


9/9/2008
CVBT Announces First Site to Begin Patient Enrollment for Its Phase II Heart Trial


7/1/2008
Dutton Associates Announces Investment Opinion: CardioVascular BioTherapeutics Maintained At Neutral Rating By Dutton Associates


6/10/2008
CVBT Inks Third Clinical Development Agreement